Search Orphan Drug Designations and Approvals
-
Generic Name: | bispecific T-cell engager antibody consisting of 2 single chain variable fragment binding domains specific for antigen Delta-like protein 3 (DLL3) and for TCR-associated complex CD3 |
---|---|
Date Designated: | 12/27/2018 |
Orphan Designation: | Treatment of small cell lung cancer (SCLC) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen Inc. 1 Amgen Center Drive Mail Stop 27-2-D Thousand Oaks, California 91320 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-